BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31406980)

  • 1. Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
    Weimers P; Halfvarson J; Saunders-Pullman R; Ludvigsson JF; Peter I; Olén O; Burisch J
    Inflamm Bowel Dis; 2019 Sep; 25(10):e127. PubMed ID: 31406980
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Peter I; Dubinsky M; Xuan S; Chen N; Wang A
    Inflamm Bowel Dis; 2022 Jun; 28(6):e72. PubMed ID: 35267013
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to the Letter to the Editor: "Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease".
    Coates MD; Ba DM; Liu G; Dalessio S; Leslie DL; Huang X
    Inflamm Bowel Dis; 2022 Jun; 28(6):e73-e74. PubMed ID: 35358300
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between inflammatory bowel disease and Parkinson's disease: seek and you shall find?
    Weimers P; Halfvarson J; Sachs MC; Ludvigsson JF; Peter I; Olén O; Burisch J
    Gut; 2019 Jan; 68(1):175-176. PubMed ID: 30021791
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammatory bowel disease and Parkinson's disease.
    Lynge E; Petersen MS; Lophaven SN
    Gut; 2020 May; 69(5):970. PubMed ID: 31076400
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased Risk of Parkinson Disease in Inflammatory Bowel Disease Patients.
    Lai SW; Kuo YH; Liao KF
    Inflamm Bowel Dis; 2019 Sep; 25(10):e125-e126. PubMed ID: 31406986
    [No Abstract]   [Full Text] [Related]  

  • 7. In reply to the letter to the editor regarding "Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study".
    Zenesini C; Baldin E; Vignatelli L; D'Alessandro R
    J Neurol Sci; 2020 Jan; 408():116511. PubMed ID: 31732173
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Letter to the Editor of Dr. Lai and Colleagues.
    Shmidt E; Saha S; Sands BE
    Inflamm Bowel Dis; 2019 Nov; 25(12):e166. PubMed ID: 31622457
    [No Abstract]   [Full Text] [Related]  

  • 9. Older patients with IBD might have higher risk of Parkinson's disease.
    Wan QY; Zhao R; Wu XT
    Gut; 2020 Jan; 69(1):193-194. PubMed ID: 30518530
    [No Abstract]   [Full Text] [Related]  

  • 10. Which way does the axis tip? IBD increases the risk of Parkinson's disease.
    Hutfless S; Wenning GK
    Gut; 2019 Jan; 68(1):3. PubMed ID: 29858394
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory bowel disease and risk of Parkinson's disease.
    Pinel-Ríos J; Madrid-Navarro CJ; Pérez-Navarro MJ; Campos-Arillo V; Mínguez-Castellanos A; Escamilla-Sevilla F
    Parkinsonism Relat Disord; 2018 Dec; 57():78-79. PubMed ID: 30580772
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory bowel disease and risk of Parkinson's disease in medicare beneficiaries.
    Camacho-Soto A; Searles Nielsen S; Racette BA
    Parkinsonism Relat Disord; 2018 Dec; 57():77. PubMed ID: 29983328
    [No Abstract]   [Full Text] [Related]  

  • 13. Authors' response: Association between IBD and Parkinson's disease: seek and you shall find?
    Villumsen M; Aznar S; Pakkenberg B; Brudek T; Jess T
    Gut; 2019 Sep; 68(9):1722. PubMed ID: 30158253
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Weimers P; Halfvarson J; Sachs MC; Saunders-Pullman R; Ludvigsson JF; Peter I; Burisch J; Olén O
    Inflamm Bowel Dis; 2019 Jan; 25(1):111-123. PubMed ID: 29788069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to Letter to Editor of Dr. Elia.
    Bernstein CN; Shafer LA; Singh H; Targownik L
    Inflamm Bowel Dis; 2019 Jan; 25(2):e9. PubMed ID: 29800145
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to letter to the editor "Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges".
    Velisar A; Bronte-Stewart H
    Brain Stimul; 2019; 12(5):1330-1331. PubMed ID: 31235368
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to the Letter to the Editor "The Microbiota in Parkinson's Disease: Ranking the Risk of Heart Disease".
    Hirayama M; Ohno K
    Ann Nutr Metab; 2022; 78(2):119-120. PubMed ID: 35042218
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to letter to the editor "tDCS effect on cognitive performance in Parkinson's disease" by Biundo et al.
    Cotelli M; Manenti R; Brambilla M; Borroni B
    Mov Disord; 2016 Aug; 31(8):1253-5. PubMed ID: 27270985
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to: 'Letter to the Editor on "Sex Differences in Parkinson's Disease Phenotype and Caregiving Disparities"'.
    Antar T; Iwaki H; B Singleton A
    Mov Disord; 2021 Feb; 36(2):527-528. PubMed ID: 33599005
    [No Abstract]   [Full Text] [Related]  

  • 20. In reply to the letter to the editor regarding "TGM6 variants in Parkinson's disease: clinical findings and functional evidence".
    Chen K; Tan Y; Zhao YX
    J Integr Neurosci; 2020 Dec; 19(4):739-740. PubMed ID: 33378850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.